Cargando…

Malignant tumours of temporomandibular joint

BACKGROUND: Malignant tumours of the temporomandibular joint (MTTMJ) are extremely rare. Studies describing its unique epidemiology, clinicopathological features, treatment and prognosis comprehensively are limited. To address these issues, current investigation was performed. METHODS: A retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yibulayin, Feiluore, Yu, Chen-xi, Feng, Lei, Wang, Meng, Lu, Meng-meng, Luo, Yuan, Liu, Hui, Yang, Zhi-cheng, Wushou, Alimujiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539439/
https://www.ncbi.nlm.nih.gov/pubmed/33023507
http://dx.doi.org/10.1186/s12885-020-07425-9
_version_ 1783591054178516992
author Yibulayin, Feiluore
Yu, Chen-xi
Feng, Lei
Wang, Meng
Lu, Meng-meng
Luo, Yuan
Liu, Hui
Yang, Zhi-cheng
Wushou, Alimujiang
author_facet Yibulayin, Feiluore
Yu, Chen-xi
Feng, Lei
Wang, Meng
Lu, Meng-meng
Luo, Yuan
Liu, Hui
Yang, Zhi-cheng
Wushou, Alimujiang
author_sort Yibulayin, Feiluore
collection PubMed
description BACKGROUND: Malignant tumours of the temporomandibular joint (MTTMJ) are extremely rare. Studies describing its unique epidemiology, clinicopathological features, treatment and prognosis comprehensively are limited. To address these issues, current investigation was performed. METHODS: A retrospective research was carried out by using population-based data from the Surveillance, Epidemiology, and End Results database (1973–2016). RESULTS: Data for a total of 734 patients, including 376 men and 358 women, was found. The median age was 47 years. The 5-year and 10-year disease specific survival (DSS) rates were 69.2 and 63.6%, respectively. Significant differences in DSS were found according to age, race, tumour type, AJCC/TNM stage, surgery, radiotherapy, chemotherapy and different treatment modalities (P < 0.05). In the multivariate survival analysis, age > 44 years and AJCC stage III and IV were associated with poor DSS. CONCLUSION: MTTMJ was mostly found in white people with a median age of 47 years without any sex predominance. Patient’s age and AJCC stage was independent predictor of DSS.
format Online
Article
Text
id pubmed-7539439
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75394392020-10-08 Malignant tumours of temporomandibular joint Yibulayin, Feiluore Yu, Chen-xi Feng, Lei Wang, Meng Lu, Meng-meng Luo, Yuan Liu, Hui Yang, Zhi-cheng Wushou, Alimujiang BMC Cancer Research Article BACKGROUND: Malignant tumours of the temporomandibular joint (MTTMJ) are extremely rare. Studies describing its unique epidemiology, clinicopathological features, treatment and prognosis comprehensively are limited. To address these issues, current investigation was performed. METHODS: A retrospective research was carried out by using population-based data from the Surveillance, Epidemiology, and End Results database (1973–2016). RESULTS: Data for a total of 734 patients, including 376 men and 358 women, was found. The median age was 47 years. The 5-year and 10-year disease specific survival (DSS) rates were 69.2 and 63.6%, respectively. Significant differences in DSS were found according to age, race, tumour type, AJCC/TNM stage, surgery, radiotherapy, chemotherapy and different treatment modalities (P < 0.05). In the multivariate survival analysis, age > 44 years and AJCC stage III and IV were associated with poor DSS. CONCLUSION: MTTMJ was mostly found in white people with a median age of 47 years without any sex predominance. Patient’s age and AJCC stage was independent predictor of DSS. BioMed Central 2020-10-06 /pmc/articles/PMC7539439/ /pubmed/33023507 http://dx.doi.org/10.1186/s12885-020-07425-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yibulayin, Feiluore
Yu, Chen-xi
Feng, Lei
Wang, Meng
Lu, Meng-meng
Luo, Yuan
Liu, Hui
Yang, Zhi-cheng
Wushou, Alimujiang
Malignant tumours of temporomandibular joint
title Malignant tumours of temporomandibular joint
title_full Malignant tumours of temporomandibular joint
title_fullStr Malignant tumours of temporomandibular joint
title_full_unstemmed Malignant tumours of temporomandibular joint
title_short Malignant tumours of temporomandibular joint
title_sort malignant tumours of temporomandibular joint
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539439/
https://www.ncbi.nlm.nih.gov/pubmed/33023507
http://dx.doi.org/10.1186/s12885-020-07425-9
work_keys_str_mv AT yibulayinfeiluore malignanttumoursoftemporomandibularjoint
AT yuchenxi malignanttumoursoftemporomandibularjoint
AT fenglei malignanttumoursoftemporomandibularjoint
AT wangmeng malignanttumoursoftemporomandibularjoint
AT lumengmeng malignanttumoursoftemporomandibularjoint
AT luoyuan malignanttumoursoftemporomandibularjoint
AT liuhui malignanttumoursoftemporomandibularjoint
AT yangzhicheng malignanttumoursoftemporomandibularjoint
AT wushoualimujiang malignanttumoursoftemporomandibularjoint